Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory L Smoot

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Journal of Surgical Oncology|July 26, 2021
Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumorsHallbera Gudmundsdottir, Rondell P Graham, Mohamad B Sonbol, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 21, 2006
A single-center experience with inflammatory breast cancer, 1985-2003Rory L Smoot, Cody A Koch, Amy C Degnim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 26, 2023
Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resectionAndrea Zironda, Chi Zhang, Courtney Day, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 23, 2016
Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristicsJohn R Bergquist, Ryan T Groeschl, Tommy Ivanics, et al.
Journal of Surgical Oncology|September 5, 2024
Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal AdenocarcinomaHala Muaddi, Andrea Zironda, Chi Zhang, et al.
Journal of the American College of Surgeons|May 9, 2023
Technical Outcomes of Porto-Mesenteric Venous Reconstruction in Pancreatic Resection Using Autologous Left Renal Vein Graft as ConduitAlessandro Fogliati, Guido Fiorentini, Roberto Alva-Ruiz, et al.
Surgery|August 15, 2016
Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer DatabaseChristopher R Shubert, John R Bergquist, Ryan T Groeschl, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2016
Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?Cornelius A Thiels, John R Bergquist, Danuel V Laan, et al.
Journal of the American College of Surgeons|April 7, 2016
Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database StudyJohn R Bergquist, Carlos A Puig, Christopher R Shubert, et al.
The Journal of Trauma|April 14, 2010
Inferior vena cava filters in trauma patients: efficacy, morbidity, and retrievabilityRory L Smoot, Cody A Koch, Stephanie F Heller, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Journal of Surgical Oncology|July 26, 2021
Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumorsHallbera Gudmundsdottir, Rondell P Graham, Mohamad B Sonbol, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 21, 2006
A single-center experience with inflammatory breast cancer, 1985-2003Rory L Smoot, Cody A Koch, Amy C Degnim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 26, 2023
Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resectionAndrea Zironda, Chi Zhang, Courtney Day, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 23, 2016
Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristicsJohn R Bergquist, Ryan T Groeschl, Tommy Ivanics, et al.
Journal of Surgical Oncology|September 5, 2024
Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal AdenocarcinomaHala Muaddi, Andrea Zironda, Chi Zhang, et al.
Journal of the American College of Surgeons|May 9, 2023
Technical Outcomes of Porto-Mesenteric Venous Reconstruction in Pancreatic Resection Using Autologous Left Renal Vein Graft as ConduitAlessandro Fogliati, Guido Fiorentini, Roberto Alva-Ruiz, et al.
Surgery|August 15, 2016
Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer DatabaseChristopher R Shubert, John R Bergquist, Ryan T Groeschl, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2016
Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?Cornelius A Thiels, John R Bergquist, Danuel V Laan, et al.
Journal of the American College of Surgeons|April 7, 2016
Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database StudyJohn R Bergquist, Carlos A Puig, Christopher R Shubert, et al.
The Journal of Trauma|April 14, 2010
Inferior vena cava filters in trauma patients: efficacy, morbidity, and retrievabilityRory L Smoot, Cody A Koch, Stephanie F Heller, et al.
Pageof 16